Mepolizumab for the Treatment of Chronic Spontaneous Urticaria
Clinical trial NCT03494881 · COMPLETED
Trial details
- NCT number
- NCT03494881
- Sponsor
- Mayo Clinic
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-30
- Primary completion
- 2023-11-15
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.